Apyx Medical Corporation (APYX) vs Pulmonx Corporation (LUNG)

Apyx Medical Corporation and Pulmonx Corporation are both Medical Devices companies. Apyx Medical Corporation is the larger, with a market value of $107.8M against $79.5M — 1.4× the size. Apyx Medical Corporation grew revenue faster over the last twelve months: 25.6% against −3.43%. Apyx Medical Corporation has the higher net margin (−14.8% vs −55.0%) and the higher return on invested capital (−11.8% vs −141.0%). Across the 18 metrics below, Apyx Medical Corporation leads on 11 and Pulmonx Corporation on 7.

Valuation

Metric APYX LUNG Medical Devices median
P/E n/m n/m 23.22
P/S 1.91 0.86 2.34
P/B 10.08 1.93 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 2.20 0.65 2.24
Earnings yield (7.84%) (65.17%) (10.09%)
Free cash flow yield (9.88%) (40.57%) (8.47%)

Profitability

Metric APYX LUNG Medical Devices median
Gross margin 63.50% 77.06% 56.01%
Operating margin (6.06%) (52.96%) (15.03%)
Net margin (14.78%) (55.03%) (20.40%)
Free cash flow margin (18.91%) (35.07%) (7.24%)
Return on equity (93.11%) (88.87%) (15.32%)
Return on assets (14.48%) (36.74%) (19.72%)
Return on invested capital (11.76%) (141.03%) (10.33%)

Growth

Metric APYX LUNG Medical Devices median
Revenue growth (TTM) 25.59% (3.43%) 8.80%
EPS growth (last fiscal year) 59.09% 7.64% 29.03%
Revenue growth, 5-year CAGR 13.78% 22.55% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APYX LUNG Medical Devices median
Debt to equity 3.19 0.95 0.07
Current ratio 5.68 4.32 2.50
Net debt to EBITDA (0.54) 0.62 0.49

Dividend

Metric APYX LUNG Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric APYX LUNG Medical Devices median
Market cap 107.84m 79.46m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack